Abstract
To overcome solubility problem observed in early preclinical study with the potent multidrug resistance reversing agent HZ08 which containing tetrahydroisoquinoline skeleton, we synthesized a series of HZ08 analogues with improved soluble properties. Compounds 6f, 10c and 10f showed significant reversal activity with little cytotoxicity. The median inhibitory concentration (IC50) values of adriamycin were reduced to 0.9 μM, 1.1 μM and 0.71 μM, respectively and comparable to those of reference drug verapamil (1.1 μM) and lead compound HZ08 (0.8 μM) on K562/A02 cells. The solubility of all newly synthesized compounds had been improved.
Keywords: Multidrug resistance, Anticancer, Tetrahydroisoquinoline, Solubility, P-glycoprotein, THIQ, cytotoxicity, Qingdao, humidified atmosphere
Letters in Drug Design & Discovery
Title:Evaluation of In-Vitro Multidrug Resistance Reversal Activities of HZ08 analogues with Improved Soluble Property
Volume: 10 Issue: 1
Author(s): Xiaobu Lan, Haiyan Lin, Chunlei Tang, Xiaoyun Zhu, Hai Qian, Wenlong Huang and Yunman Li
Affiliation:
Keywords: Multidrug resistance, Anticancer, Tetrahydroisoquinoline, Solubility, P-glycoprotein, THIQ, cytotoxicity, Qingdao, humidified atmosphere
Abstract: To overcome solubility problem observed in early preclinical study with the potent multidrug resistance reversing agent HZ08 which containing tetrahydroisoquinoline skeleton, we synthesized a series of HZ08 analogues with improved soluble properties. Compounds 6f, 10c and 10f showed significant reversal activity with little cytotoxicity. The median inhibitory concentration (IC50) values of adriamycin were reduced to 0.9 μM, 1.1 μM and 0.71 μM, respectively and comparable to those of reference drug verapamil (1.1 μM) and lead compound HZ08 (0.8 μM) on K562/A02 cells. The solubility of all newly synthesized compounds had been improved.
Export Options
About this article
Cite this article as:
Lan Xiaobu, Lin Haiyan, Tang Chunlei, Zhu Xiaoyun, Qian Hai, Huang Wenlong and Li Yunman, Evaluation of In-Vitro Multidrug Resistance Reversal Activities of HZ08 analogues with Improved Soluble Property, Letters in Drug Design & Discovery 2013; 10 (1) . https://dx.doi.org/10.2174/1570180811309010056
DOI https://dx.doi.org/10.2174/1570180811309010056 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Systemic and Biophase Bioavailability and Pharmacokinetics of Nanoparticulate Drug Delivery Systems
Current Drug Delivery Hemisynthesis of Selected Embelin Analogs and Investigation of their Proapoptotic Activity Against Cancer Cells
Medicinal Chemistry New Targets of Therapy in T-Cell Lymphomas
Current Drug Targets On the Involvement of H2S in Nitroso Signaling and Other Mechanisms of H2S Action
Current Pharmaceutical Biotechnology In Silico Discovery and Virtual Screening of Multi-Target Inhibitors for Proteins in Mycobacterium tuberculosis
Combinatorial Chemistry & High Throughput Screening Plasmid-Mediated Muscle-Targeted Gene Therapy for Circulating Therapeutic Protein Replacement: A Tale of the Tortoise and the Hare?
Current Gene Therapy KRAB-Zinc Finger Proteins: A Repressor Family Displaying Multiple Biological Functions
Current Genomics Impact of Immunogenetic Polymorphisms in Bone Marrow Failure Syndromes
Mini-Reviews in Medicinal Chemistry Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
Current Cancer Drug Targets Regulation of Arylamine N-Acetyltransferases
Current Drug Metabolism Conjugates of Classical DNA/RNA Binder with Nucleobase: Chemical, Biochemical and Biomedical Applications
Current Medicinal Chemistry Transposable Elements in Cancer and Other Human Diseases
Current Cancer Drug Targets In Situ Gene Therapy for Prostate Cancer
Current Gene Therapy New Drugs for Follicular Lymphoma in Older Adults
Anti-Cancer Agents in Medicinal Chemistry Second-Generation Tyrosine Kinase Inhibitors as First-Line Treatment Strategy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients
Current Cancer Drug Targets Immunoconjugates for Cancer Targeting: A Review of Antibody-Drug Conjugates and Antibody-Functionalized Nanoparticles
Current Medicinal Chemistry Power from the Garden: Plant Compounds as Inhibitors of the Hallmarks of Cancer
Current Medicinal Chemistry Never Sleep with Baby? Or Keep Me Close But Keep Me Safe: Eliminating Inappropriate “Safe Infant Sleep” Rhetoric in the United States
Current Pediatric Reviews Targeting Myc in Pediatric Malignancies of the Central and Peripheral Nervous System
Current Cancer Drug Targets Sources of β-Cells for Cell Therapy in Diabetes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)